P. M. Carli

TL;DR: EUROCARE-3 as mentioned in this paper analyzed the survival of 1815584 adult cancer patients diagnosed from 1990 to 1994 in 22 European countries and found that survival was highest in northern Europe (Sweden, Norway, Finland and Iceland), and fairly good in central-southern Europe (France, Switzerland, Austria and Spain).

TL;DR: The European Childhood Leukaemia - Lymphoma Incidence Study (ECLIS) as discussed by the authors was designed to address concerns about a possible increase in the risk of cancer in Europe following the nuclear accident in Chernobyle in 1986.

TL;DR: The aims of the European Network of Cancer Registries (ENCR) are to improve the quality, comparability and availability of cancer registry data in Europe and this paper presents the most recent available data, with short-term projections to 1995, and a commentary based, where possible, on epidemiological research carried out in France.

TL;DR: The objective of the European Childhood Leukaemia-Lymphoma Incidence Study (ECLIS) is to investigate trends in incidence rates of childhood leukaemia and lymphoma in Europe, in relation to the exposure to radiation which resulted from the Chernobyl nuclear power plant in April 1986.

TL;DR: The results indicate that intense clusters are a rare phenomenon that merit careful investigation, although aetiological insights are more likely to come from investigation of large numbers of cases.